Mountain View, CA - September 14, 2012 - 23andMe, the leading personal genetics company, today announced that it will open its application programming interface (API) to third-party developers, beginning September 17, 2012, following a presentation by Mike Polcari, the company's Director of Engineering, at the Quantified Self Conference in Palo Alto, Calif., on September 16th. 23andMe's open API is designed to allow authorized developers to build a broad range of new applications and tools for the 23andMe community generated from the company's data sets.
"Opening our API offers an immense opportunity for customers to do more with their DNA," stated 23andMe CEO and Co-Founder Anne Wojcicki. "While 23andMe has created a number of groundbreaking and innovative tools for our customer to explore their DNA, the API will open the door to the possibility of new web-based interactive tools to be developed by external groups."
23andMe's API will require individual-level consent for all data that may be referenced by third-party developers in their applications. Approved developers will receive an authentication key that provides secure access to the platform. Developers can apply to access 23andMe's API at https:/
The Quantified Self Conference brings together technologists, designers, users, entrepreneurs, scientists, health professionals and media to discuss new ideas and collaboration tools that will advance self-tracking projects. "The Quantified Self movement has already expressed interest in an API for the 23andMe platform," added Mike Polcari, director of engineering at 23andMe. "We anticipate a comparable level of interest from the broader developer community for our early-access API program."
An ongoing service, 23andMe's Personal Genome Service® provides a wealth of information about an individual's DNA and updates about new research. Customers can also choose to participate in the company's unique research programs. By completing online surveys, customers contribute directly to genetic research that can potentially lead to better understanding of and new treatments for a variety of health conditions. To learn more, visit www.23andMe.com.
23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at www.23andMe.com.